Novel Tissue Factor Inhibition for Thromboprophylaxis in COVID-19: Primary Results of the ASPEN-COVID-19 Trial
Hess et al., Arteriosclerosis, Thrombosis, and Vascular Biology, doi:10.1161/ATVBAHA.122.318748
https://c19early.org/hess2.html